Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Dobutamine recalled?

Yes — there is an active recall. 1 ongoing FDA recall mention Dobutamine (9 total). Check the affected lots below.

Most common reason: Sterility / contamination (5 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Dobutamine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Dobutamine recalls on record

none so far in 2026; 9 on record, newest first
Class II · Moderate risk

DOBUTamine Injection

Discoloration: Firm received complaints of product discoloration and particulates.

Terminated Failed specification Hospira Inc. NDC 0409-2025-20 D-1500-2016
Class II · Moderate risk

Dobutamine Hydrochloride active pharmaceutical ingredient…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-635-2015
Class I · High risk

DOBUTamine Injection

Presence of Particulate Matter: Discolored solution due to a chip in the glass at the neck of the vial, also glass particulate was found within the solution.

Terminated Particulate / foreign matter Hospira Inc. NDC 0409-2344-02 D-1540-2014